Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,533
archived clinical trials in
Chronic Obstructive Pulmonary Disease

Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Gaffney, SC
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Gaffney, SC
Click here to add this to my saved trials
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Greenville, SC
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Greenville, SC
Click here to add this to my saved trials
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Seneca, SC
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Seneca, SC
Click here to add this to my saved trials
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Simpsonville, SC
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Simpsonville, SC
Click here to add this to my saved trials
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Spartanburg, SC
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Union, SC
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Union, SC
Click here to add this to my saved trials
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Amarillo, TX
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Amarillo, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Boerne, TX
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Boerne, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
El Paso, TX
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
El Paso, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Kingwood, TX
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Kingwood, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Plano, TX
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Plano, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
Novartis
mi
from
San Antonio, TX
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
Novartis
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Richmond, VA
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Richmond, VA
Click here to add this to my saved trials
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Greenfield, WI
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Greenfield, WI
Click here to add this to my saved trials
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Saint Charles, MO
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Saint Charles, MO
Click here to add this to my saved trials
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Saint Louis, MO
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
319, Novartis Investigational Site
mi
from
Mount Pleasant, SC
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
319, Novartis Investigational Site
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Rock Hill, SC
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Rock Hill, SC
Click here to add this to my saved trials
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Fort Worth, TX
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, Two-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation.
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Evaluating the Clinical Effectiveness of 3D Printing for a Patient-specific Silicone Stent Airway Implant
Small Feasibility Study for Evaluating the Clinical Effectiveness of 3D Printing for a Patient-specific Silicone Stent Airway Implant
Status: Enrolling
Updated:  3/6/2018
Cleveland Clinic
mi
from
Cleveland, OH
Evaluating the Clinical Effectiveness of 3D Printing for a Patient-specific Silicone Stent Airway Implant
Small Feasibility Study for Evaluating the Clinical Effectiveness of 3D Printing for a Patient-specific Silicone Stent Airway Implant
Status: Enrolling
Updated: 3/6/2018
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2
Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2
Status: Enrolling
Updated:  3/7/2018
Texas A&M University
mi
from
College Station, TX
Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2
Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2
Status: Enrolling
Updated: 3/7/2018
Texas A&M University
mi
from
College Station, TX
Click here to add this to my saved trials
Casein Protein and Leucine Supplementation in Chronic Obstructive Pulmonary Disease (COPD)
Casein Protein and Leucine Supplementation to Induce Anabolism in COPD Patients and Healthy Elderly
Status: Enrolling
Updated:  3/7/2018
Texas A&M University
mi
from
College Station, TX
Casein Protein and Leucine Supplementation in Chronic Obstructive Pulmonary Disease (COPD)
Casein Protein and Leucine Supplementation to Induce Anabolism in COPD Patients and Healthy Elderly
Status: Enrolling
Updated: 3/7/2018
Texas A&M University
mi
from
College Station, TX
Click here to add this to my saved trials
Fat Metabolism in OSA and COPD
Fat Metabolism and Digestion in Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  3/7/2018
Texas A&M University
mi
from
College Station, TX
Fat Metabolism in OSA and COPD
Fat Metabolism and Digestion in Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 3/7/2018
Texas A&M University
mi
from
College Station, TX
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Montgomery, AL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Montgomery, AL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Burbank, CA
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Burbank, CA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Greenbrae, CA
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Greenbrae, CA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Clearwater, FL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Hollywood, FL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Hollywood, FL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Jacksonville, FL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
New Port Richey, FL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Ocala, FL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Belvidere, IL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Belvidere, IL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Chicago, IL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Springfield, IL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Springfield, IL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Topeka, KA
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Louisville, KY
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Baltimore, MD
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Brockton, MA
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Brockton, MA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Omaha, NE
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Las Vegas, NV
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Charlotte, NC
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Morehead City, NC
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Morehead City, NC
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Kettering, OH
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Kettering, OH
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Medford, OR
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Medford, OR
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Downingtown, PA
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Downingtown, PA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Levittown, PA
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Levittown, PA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Sellersville, PA
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Sellersville, PA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Simpsonville, SC
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Simpsonville, SC
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Spartanburg, SC
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Spartanburg, SC
Click here to add this to my saved trials